Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma, Follicular × Selenium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Unspecified Adult Solid Tumor, Protocol Specific 2 Male Urogenital Diseases 2 Urinary Bladder Neoplasms 1 Thyroid Nodule 1 Prevention of Colorectal Cancer 1 Polyps 1 Ovarian Neoplasms 1 Non-melanoma Skin Cancer 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Inflammation 1 Fallopian Tube Neoplasms 1 Colonic Neoplasms 1 Arsenic Poisoning 1

Interventions

Cyclophosphamide 161 Rituximab 148 fludarabine phosphate 84 Peripheral Blood Stem Cell Transplantation 79 Filgrastim 65 Etoposide 59 Radiotherapy 57 Mycophenolic Acid 54 Whole-Body Irradiation 53 Cyclosporine 44 Lenalidomide 42 Melphalan 40 Tacrolimus 39 Busulfan 38 Prednisone 35 fludarabine 34 Vincristine 34 Antilymphocyte Serum 33 Cytarabine 31 Bendamustine Hydrochloride 29 obinutuzumab 28 Methotrexate 28 Doxorubicin 28 Carmustine 26 Methylprednisolone 23 ibritumomab tiuxetan 22 Cord Blood Stem Cell Transplantation 22 Dexamethasone 21 sargramostim 20 Bortezomib 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡